65,437 trials
ACC/AHA/NASPE Class 1, IIa or IIb Indications
Primary: Conversion of Induced Ventricular Fibrillation — 52 Participants
HIV/AIDS
Primary: HIV Self-stigmatization as Assessed Via Self Stigmatization Questionnaire — 2.93; 2.95 score on a scale
Cat Allergy · Mild Asthma
Primary: Time to Early Asthmatic Response (EAR) Upon Controlled Cat Allergen Challenge in an Environmental Exposure Unit (EEU) on Day 8 — 51; NA Minutes — p== 0.0083
Posttraumatic Stress Disorder
Primary: Change From Baseline to Primary Endpoint in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Total Severity Score — -25.00 score on a scale
Ventricular Tachycardia · Ventricular Fibrillation
Primary: Implant Success Rate at Septal Site — 97; 99 Participants
Chronic Myelogenous Leukemia
Primary: Percentage of Participants With Improvement in Imatinib Related Chronic Low Grade Non Hematologic Adverse Event (AE) After Switch to Treatment With Nilotinib at End of…
Frailty
Primary: Overall Frailty Status as Assessed by the Fried Frailty Phenotype (FFP) Screening Test. — 2; 2; 2; 3 Participants
Orthostatic Hypotension · Falls
Primary: Orthostatic Hypotension at Discharge — 39; 44 Participants — p=0.6
Cognitive Measures · Driving Simulator Performance
Primary: Number of Subjects Who Had a Driving Simulator Crash Event — 2; 0 Participants — p=0.50
Avian Influenza · Influenza Immunisation
Primary: Geometric Mean Titers (GMT) of Serum Hemagglutination Inhibition (HAI) Antibodies on Day 22 Against the 2017 Influenza A/H7N9 Vaccine Virus — 22.7; 116.1; 77.7; 190.3…
Biopsy Proven Non Small Cell Lung Cancer · Head and Neck Cancer · Gastrointestinal Cancer
Primary: Tumor Volume — 93.55 cm^3
Smoking Cessation
Primary: Number of Participants Who Enroll in Any Smoking Cessation Service in Hong Kong — 156; 158 Participants
Melanoma · Young Adult
Primary: Sun Protection Behaviors Assessed Via Questionnaires — 2.4; 3.0; 2.8; 2.3 score on a scale
Leukemia · CLL
Primary: Total Sleep Time as Measured by Polysomnography (PSG) — -25.5 Minutes
Opioid-Related Disorders
Primary: Percentage Opioid Negative Urine Tests — 234; 299 urine drug tests — p=0.07